. The crystallisation of the substance (Butenandt, 1929; Doisy et al., 1929; Marrian, 1929) was early followed by demonstration of its relation to the sterols, one of the most important biochemical groups in normal and abnormal metabolism, and eventually five naturally occurring oestrogens were isolated from the ovary, pregnancy urine and the placenta, all with an identical basic formula (1) and a similar qualitative I action. Of these, three are used clinically, (Estradiol (dihydroxyi oestrin), (Estrone (ketohydroxyoestrin) 
Synthetic (Estrogens.
It was thought until recently that the cyclo-pentenophenanthrene nucleus was an essential part of any cestrogenic substance. Workers in London and Cambridge (Dodds and Lawson, 1936; Dodds et al., 1938 a (2) Stilboestrol. developed another synthetic compound, triphenylchlorethylene (Robson and Schonberg, 1937) . These (Dodds et al., 1938$ ;  , and to be highly active orally. It is possible that they are products of the metabolism of cestradiol and have an initial immunity to breakdown by the liver .
All cestrogenic substances may be given orally, by injection, and locally through mucous membranes. The natural oestrogens are also effective percutaneously provided an organic solvent such as alcohol or benzol is used (Zondek, B., 1938) . On oral administration the synthetic oestrogens are all highly active, whereas the ratio of potency by mouth and by injection of pure natural oestrogen is 1 : 500 (Inhoffen et al., 1938) . There is / little difference in the duration of action by mouth of the same large dose of oestradiol, oestradiol benzoate, stilboestrol and triphenylchlorethylene (Robson, Schonberg and Fahim, 1938 (Robson, Schonberg and Fahim, 1938) , and in man effects have been seen six to nine weeks after two subcutaneous injections at weekly intervals of 250 mg. (Macpherson and Robertson, 1939 (Nelson, 1936 ). It appears to be antagonistic to, or at any rate to have an inhibitory effect upon, the gonadotrophic (Rowlands and Sharpey-Schafer, 1940) and lactogenic principles of the anterior pituitary (Nelson, 1936 (Donald, 1937) , hirsutism, possibly a suprarenal cortical phenomenon (Zondek, H., 1935) , and other skin ( changes. In relation to the syndrome described as menopausal it is important to notice that a symptomless cessation of the menses (" menopause ") may be followed some years later by " menopausal " (true " climacteric ") symptoms (Bishop, 1937^ ; Donald, 1938 (Fluhmann and Murphy, 1939) . From the same patients gonadotrophic hormone can almost invariably be recovered in excessive quantities ; but, while the amount of the excess appeared at first to be associated with the degree of the symptoms, it has since been shown that this excess may persist for the remainder of life, long after the symptoms have disappeared (Heller and Heller, 1939 (Papanicolaou, 1933 (Dobszay, 1936 ; Cruickshank and Sharman, 1934 (Bishop et al., 1939) , and yet a third 400 to 1200 mg. of triphenylchlorethylene daily by mouth, or 250 to 750 mg. monthly by injection (Macpherson and Robertson, 1939 (Jeffcoate, 1937 Broadly speaking, in the human, oestrogen is probably responsible for the growth of the duct system and with progesterone will cause alveolar hyperplasia (Nelson, 1936) . This is a possible and simple explanation of the enlargement of the breasts which normally occurs in pregnancy.
Thus oestrogen has, as upon all the secondary sexual apparatus, a direct stimulatory effect upon the breast. It has already been pointed out, firstly, that at the onset of parturition the quantity of circulating blood cestrin is enormous (Browne et (Bishop, 1937#) .
CEstrin is secreted throughout the menstrual cycle, but its proliferative action on the endometrium is limited to the first half of the cycle.
In the second half the hormone of the corpus luteum, for whose action both prestimulation by oestrin and its simultaneous presence are essential (Robson, 1934) , not only inhibits the action of oestrin but, by its own action upon the endometrium, prevents the occurrence of oestrin withdrawal bleeding (Corner, 1939 (Robson, 1937) . Before jumping to the conclusion that a case of amenorrhoea *s one of primary sex-endocrine hypofunction, other possible causes must first be excluded, for example anaemia, tuberculosis, change of environment, emotional disturbance, hyperthyroidism, obesity and pituitary disorders generally. Thereafter, amenorrhoea is usually due to a sub-threshold effect of oestrin upon the uterus with resultant hypoplasia of muscle n.s. iv., xlvii. no. 6. 417 2 F and endometrium (Bishop, 1937# (Haultain, 1933 It is essential to remember that thorough investigation of the genital functions of both parties should precede any attempt at endocrine therapy in the female (Meaker, 1934 (Novak, 1934; Jeffcoate, 1935) , and where this does occur the aim of therapy is to stimulate ovulation. Gonadotrophic hormones are usually employed for this purpose, but successful treatment has been described by the technique of Where there is apparent genital hypoplasia, whether vaginal, uterine or tubal, benefit will, and success may, be obtained by concentrated cestrogenic therapy similar to that for hypoplastic amenorrhoea (Clauberg, 1935 (Caffier, 1938  Marrian and Parkes, 1930 ; Hemmingsen, 1933) , an<^ *n some species cannot be obtained with oestrogenic hormone alone (Dempsey et al., 193^) (Lacassagne, 1932 (Lacassagne, , 1933 (Lacassagne, , 1934 Gardner et al., 1935) . It has been demonstrated (Geschickter, 1939) that administration of sufficient oestrogen by injection or pellet implantation produced mammary carcinoma in 25 out of 86 rats (in whom spontaneous breast cancer is very rare). This work awaits confirmation, however, for Emge (1939) (Buxton and Engle, 1939 (Moore, 1932) . This is a factor which must be taken into account in the young, and counsels the advisability of intermittent administration.
In the elder patient continuous treatment may cause tender swelling of the breasts, cystic endometrial hyperplasia, or weakness, headaches and loss of appetite?these latter probably by pituitary inhibition (Editorial, Lancet, 1936 ; Donald, 1939) or exhaustion (Severinghaus, 1939) .
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